Medical Prognosis Institute AS (MPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Medical Prognosis Institute AS (MPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH110071D
  • |
  • Pages: 32
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers drug response prediction platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue repositioning repurposing, patient selection, drug combinations, pathway elucidation, new indications, indication selection and companion diagnostic programs. MPI also offers drug specific interface to the human genome and predict drug response in individual patients. The company has partnerships with various cancer drug developing companies. It operates in Denmark and the US. MPI is headquartered in Horsholm, Denmark.

Medical Prognosis Institute AS (MPI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Medical Prognosis Institute A/S, Medical Devices Deals, 2012 to YTD 2018 9

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Oncology Venture Raises USD0.56 Million in Venture Financing 11

Partnerships 12

Medical Prognosis Institute Enters into Co-Development Agreement with Alion Pharma 12

Merger 13

Oncology Venture to Merger with Medical Prognosis Institute 13

Licensing Agreements 14

Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute 14

Asset Transactions 15

Oncology Venture Acquires Drug Response Predictor from Medical Prognosis Institute 15

Medical Prognosis Institute A/S-Key Competitors 16

Medical Prognosis Institute A/S-Key Employees 17

Medical Prognosis Institute A/S-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Financial Announcements 19

Mar 23, 2018: MPI publishes Annual report for 2017 19

Mar 13, 2018: Medical Prognosis Institute publishes selected financial information for the period 1 July 2017-31 December 2017 due to the proposed merger between Medical Prognosis Institute and Oncology Venture 22

Aug 31, 2017: MPI publishes Half-year Report for the first half of 2017 23

Corporate Communications 25

May 31, 2018: MPI-Change in Board of directors 25

Other Significant Developments 26

Jul 02, 2018: Oncology Venture Sweden: Strong LiPlaCis Treatment Results in DRP-Selected Breast Cancer Patients Collaborative LiPlaCis Regulatory Meeting with DKMA 26

Jul 02, 2018: MPI-Strong LiPlaCis Treatment Results in DRP-Selected Breast Cancer Patients-Collaborative LiPlaCis Regulatory Meeting with DKMA 29

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32

List of Figures

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Medical Prognosis Institute A/S, Medical Devices Deals, 2012 to YTD 2018 9

List of Tables

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Medical Prognosis Institute A/S, Deals By Therapy Area, 2012 to YTD 2018 8

Medical Prognosis Institute A/S, Medical Devices Deals, 2012 to YTD 2018 9

Medical Prognosis Institute A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Oncology Venture Raises USD0.56 Million in Venture Financing 11

Medical Prognosis Institute Enters into Co-Development Agreement with Alion Pharma 12

Oncology Venture to Merger with Medical Prognosis Institute 13

Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute 14

Oncology Venture Acquires Drug Response Predictor from Medical Prognosis Institute 15

Medical Prognosis Institute A/S, Key Competitors 16

Medical Prognosis Institute A/S, Key Employees 17

Medical Prognosis Institute A/S, Subsidiaries 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Medical Prognosis Institute AS, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17840
Site License
USD 500 INR 35680
Corporate User License
USD 750 INR 53520

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com